Cannabigerovarin

Cannabigerovarin (CBGV), the propyl homolog of cannabigerol (CBG), is a cannabinoid present in Cannabis.^[1][2][3][4] There is no observation related to the psychoactive or psychotropic effects of CBGV when consumed or inhaled.^[5][1]

Cannabigerovarin

Names
IUPAC name 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-propylbenzene-1,3-diol
Other names Cannabigerovarol CBGV
Identifiers
CAS Number	55824-11-8
3D model (JSmol)	Interactive image
ChemSpider	32702027
PubChem CID	59444407
UNII	34S78SNA69
CompTox Dashboard (EPA)	DTXSID601345013
InChI InChI=1S/C19H28O2/c1-5-7-16-12-18(20)17(19(21)13-16)11-10-15(4)9-6-8-14(2)3/h8,10,12-13,20-21H,5-7,9,11H2,1-4H3/b15-10+
SMILES CCCC1=CC(=C(C(=C1)O)C/C=C(\C)/CCC=C(C)C)O
Properties
Chemical formula	C19H28O2
Molar mass	288.431 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Usages

The possible benefits of cannabigerovarin in human bodies are painkilling and anti-inflammatory properties to treat conditions like fibromyalgia and arthritis, the treatment and improvement of the dry-skin syndrome, cancer treatment by reducing the growth of cancer cells in patients who have leukemia.^{[6][5][7][8][9]}

According to the pain-relieving effects of this natural cannabinoid, it can be helpful to treat patients who were undergoing drug exposure like chemotherapy or radiation therapy.^[10][9] In addition, cannabigerol metabolism increases and has a better absorption from the body when paired with cannabigerovarin.^[11]